About
Generic Ophthalmology, Dermatology Products
Areas of Focus
Categories
Generic Drug
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
439
By Phase
NA: 5PHASE1: 1
By Status
COMPLETED: 4UNKNOWN: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06607237Lead Sponsor
Evaluation of Safety and Efficacy of DM-28 for Treatment of Moderate to Severe Ocular Dryness
NACompleted
44 participants
Started: Sep 26, 2024 · Completed: Jan 9, 2025
NCT06245421Lead Sponsor
Evaluation of the Efficacy and Safety of DM934 Versus Théalose on Eye Dryness
NACompleted
85 participants
Started: Mar 7, 2024 · Completed: Sep 30, 2024
NCT05191771Lead Sponsor
Evaluation of Neovis® Total Multi Versus Systane® Balance on Ocular Dryness Associated With Meibomian Gland Dysfunction
NAUnknown
120 participants
Started: Jan 31, 2022 · Completed: Dec 31, 2022
NCT05006768Collaborator
Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands)
PHASE1Completed
30 participants
Started: May 5, 2021 · Completed: Jun 24, 2021
NCT03645850Lead Sponsor
Evaluation of Efficacy and Safety of Vismed Gel Multi 0.3% Versus Vismed Multi 0.18% on Treatment of Ocular Dryness
NAUnknown
80 participants
Started: Sep 1, 2018 · Completed: Jun 15, 2019
Locations (1)
Headquarters
Nice, France
Map
Loading map...